EPHB2 and obesity due to melanocortin 4 receptor deficiency: Anti-inflammatory therapy targeting macrophage infiltration or inhibiting the silencing of EphB2 may offer novel approaches for inhibiting obesity-associated colorectal cancer development and progression.